IVAM Virtual Meeting - Society of Toxicology · 5/22/2020  · submit proposals to IVAM no later...

Post on 26-Jul-2020

2 views 0 download

Transcript of IVAM Virtual Meeting - Society of Toxicology · 5/22/2020  · submit proposals to IVAM no later...

IVAM Virtual Meeting

WebEx May 22, 2020

Opening RemarksKelly Coleman, President, IVAM

Agenda

Ø Year in Review

Ø Treasurer’s Report

Ø SOT Meeting Proposals

Ø Recognitions

Ø Upcoming Meetings

Year in Review

Kelly Coleman, President, IVAM

Outgoing IVAM officers• Pam Spencer, President

• Kelly Coleman, Vice President

• Kathryn Page, Counselor

• Jill Merrill, Secretary/Treasurer

• Leah M. Norona, Postdoctoral Representative

• Belkys González, Student Representative

Incoming IVAM officers

PRESIDENTDr. Kelly Coleman, Medtronic

VICE PRESIDENTDr. Sean Gehen, Corteva Agriscience

VICE PRESIDENT-ELECTDr. Kathryn Page, Clorox

Incoming IVAM officersSECRETARY/TREASURER

Dr. Helena Hogberg, CAAT, Johns Hopkins

COUNCILORDr. Samantha Faber, Takeda Pharmaceuticals

POSTDOCTORAL REPRESENTATIVEDr. Megan Culbreth, EPA NCCT

GRADUATE STUDENT REPRESENTATIVEAmanda Dhaneshwar, B.S., M.S., St. John’s University

IVAM Webinars• 2019 Student Research Award Winners

Piecing Together the Puzzle: Identifying the Role Oxidative Stress and the Alveolar Epithelium Play in Air Pollution Induced Cardiovascular DiseasePresented by Eva Vitucci

Functional Comparison of HepaRG Cells and Primary Human Hepatocytes in Monolayer and Spheroid Culture as Repeated Exposure Models for HepatotoxicityPresented by Jinpeng Li

• NAMs Case Study: Industry/Government PartnershipsMonique Perron, ScDActing Branch Chief, Risk Assessment Branch IVUS EPA, OPP, HED

Douglas C. Wolf, DVM, PhD, FIATP, ATSSenior Syngenta Fellow, Product Safety

Revised Bylaws

• In 2019 the IVAM Executive Committee voted to:

• Eliminate the Vice Postdoctoral Representative position.

• Extend the Postdoctoral Representative term to two years.

• Changes need to be approved by IVAM members

• Then approved by SOT’s Council

IVAM Membership 2020

Treasurer’s Report

Helena Hogberg, Secretary/Treasurer IVAM

Treasurer’s Report

o Net assets beginning of year: $10,522

o Income: $1,000

o Expenses (awards & plaques): $589

o Net assets end of year: $10,933

SOT Meeting Proposals 2020-2021

Sean Gehen, Vice President, IVAM

2020 Annual Meeting – Session Proposals31 sessions requesting endorsement

(29 were endorsed)

• 13 Symposia

• 13 Workshops• 4 CE Courses

• 1 Informational

2021 Annual Meeting – Session Proposals

Now – June 12 August Open Mid-September

60th Annual Meeting and ToxExpoMarch 14-18, 2021 | Orlando, Florida

• SOT Deadline: June 12, 2020

• To ensure IVAM review for potential feedback, please submit proposals to IVAM no later than May 29, 2020

• Specialty Section Communication and Collaboration Group for Cross Cutting Issues

• Continuing Education Course Submissions

IVAM will not accept proposals after May 29th!

2021 Annual Meeting – Session Proposals

RecognitionsKelly Coleman, President, IVAM

SOT Awards

Industry – Sponsored Awards

Graduate Student Award

Sarah D. Burnett, Texas A&M University

“An In Vitro Human Population Model for Screening Environmental Chemicals for the Cardiotoxicity Hazard”

Advisor: Dr. Ivan Rusyn

Postdoctoral AwardDr. Phillip W. Clapp, Center for Environmental Medicine, Asthma, and Lung Biology University of North Carolina-Chapel Hill

“An Inexpensive Open-Source In Vitro Exposure System for Uniform Sedimentation of Liquid Aerosols Generated by New and Emerging Tobacco Products”

Advisor: Dr. Ilona Jaspers

• 600 ePosters Online

• 15 More Online CE Courses and Lectures

• Through June 26, 2020

• https://www.toxicology.org/events/am/AM2020/program.asp

*AM04 CE ONLINE: Introduction to Open-Access Computational Toxicology Tools Chairs: Agnes Karmaus & Nicole Kleinsteuer (226 attendees) (4/3/20)

For more information visit: https://www.ascctox.org/qsar2021

For more information visit: https://www.ascctox.org/annualmeeting

The conference theme will address the US EPA goal to eliminate reliance on mammalian tests to make regulatory decisions by 2035, and the various considerations—science and policy—related to meeting this goal.

Confirmed Plenary speakers:

• Tara Barton-McLaren, Health Canada• Richard Keigwin, US EPA• Sue Marty, Dow Chemical• Adrian Roth, Roche

Now Virtual!

SPONSOR

Thank you to our members!